Back to Selection     Print       Date : 28 Feb 2026
Fund Summary
Tata India Pharma & HealthCare Fund Reg Plan (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Dec-15
Corpus(Cr.) 1301.0 Latest NAV 28.8922 As on 17-03-2026
Equity(%) 97.56 52 Week High 31.3901
Debt(%) 2.44 52 Week Low 27.2324
Others(%) 0.0 Exit Load 0.25% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.11
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Rajat Srivastava
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 33.02%
Top 10 Holdings 53.13%
Top 25 Holdings 92.11%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 56.3
Healthcare 37.93
Fertilisers 3.33
Cash 2.44
 
 
 
 
 
Portfolio Metrics
PB Ratio 6.55
PE Ratio 43.82
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 9.66
Max Healthcare Institute Limited 6.78
DIVI LABORATORIES LTD. 5.94
Abbott India Limited 5.60
Healthcare Global Enterprises Limited 5.04
Apollo Hospitals Enterprise Limited 5.00
Cipla Limited 4.55
Rainbow Childrens Medicare Limited 3.83
Mankind Pharma Limited 3.40
Bayer Crop Science Ltd 3.33
Fortis Health Care Ltd 3.27
Sai Life Sciences Limited 3.25
J B Chemicals and Pharma Ltd 3.21
Metropolis Healthcare Limited 3.13
Lupin Limited 3.08
Dr Reddys Laboratories Limited 3.04
Dr Lal Path Labs Ltd 2.71
Krishna Inst of Medical Sciences Ltd. 2.64
Syngene International Limited 2.39
CASH / NET CURRENT ASSET 2.24
Alkem Laboratories Limited 2.15
AFebta Pharma Limited 2.06
Neuland Laboratories Limited 2.00
Sanofi India Limited 1.99
Glaxosmithkline Pharma Ltd 1.82

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-1.94% -3.66% -6.49% 4.91%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-7.40% -8.56% -6.66% 5.93%
 
Scheme Benchmark [NSE - Nifty Pharma]
1.81% -0.06% 1.60% 9.15%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
8.81% 22.95% 15.18% 11.65%
 
 
4.69% 12.60% 11.17% 13.49%
 
 
9.85% 24.59% 13.89% 7.24%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 16.14% 1.0635 10.4494% 44.9256 0.1482
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 11.6069% 0.0002 0.2852 14.2979 0.6982
 
Back to Selection